The DNA testing company, which has 10 million customers, misses nearly 90 percent of people with risky BRCA mutations. It says the criticism is overblown.
from NYT > U.S. https://nyti.ms/2IpGT0R
Post Top Ad
Tuesday, April 16, 2019
Don’t Count on 23andMe to Detect Most Breast Cancer Risks, Study Warns
Tags
# NYT > U.S.
About Unknown
Templatesyard is a blogger resources site is a provider of high quality blogger template with premium looking layout and robust design. The main mission of templatesyard is to provide the best quality blogger templates.
NYT > U.S.
Labels:
NYT > U.S.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment